Literature DB >> 16630001

Evaluation of the Cepheid GeneXpert system for detecting Bacillus anthracis.

M P Ulrich1, D R Christensen, S R Coyne, P D Craw, E A Henchal, S H Sakai, D Swenson, J Tholath, J Tsai, A F Weir, D A Norwood.   

Abstract

AIMS: The Cepheid GeneXpert is a four-site, automated sample preparation and real-time PCR detection system. In this study, the capability of the GeneXpert to isolate and detect nucleic acid from Bacillus anthracis Ames spores was assessed. METHODS AND
RESULTS: A four-plex, dried-down bead cartridge containing PCR reagents specific for the pXO1 and pXO2 plasmids as well as sample processing and inhibition controls was evaluated. For B. anthracis Ames spores harbouring pXO1 and pXO2, samples containing 68 CFU per ml (148 spores per ml) were positive in all four replicates. A limited cross-reactivity panel, which included closely related Bacillus species, was also tested to determine the specificity of the pXO1 and pXO2 assays. No cross-reactivity occurred. Further, B. anthracis Sterne spore samples were analysed to compare results when processed using the GeneXpert to those run directly on the Cepheid SmartCycler without sample processing. The GeneXpert detection capability was three logs lower than the SmartCycler indicating the benefit of incorporating a nucleic acid extraction procedure.
CONCLUSIONS: This study demonstrates that the GeneXpert is a rapid and reliable system for simultaneously detecting the B. anthracis virulence plasmids pXO1 and pXO2. SIGNIFICANCE AND IMPACT OF THE STUDY: The GeneXpert is the only platform currently available that is capable of both nucleic acid purification and real-time PCR detection enclosed within a single system. Further, all sample manipulations are automated, thus reducing errors associated with manual processing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630001     DOI: 10.1111/j.1365-2672.2006.02810.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  18 in total

1.  Comparison of GeneXpert FluA PCR to direct fluorescent antibody and respiratory viral panel PCR assays for detection of 2009 novel H1N1 influenza virus.

Authors:  Steve Miller; Morvarid Moayeri; Carolyn Wright; Lina Castro; Mark Pandori
Journal:  J Clin Microbiol       Date:  2010-10-20       Impact factor: 5.948

Review 2.  Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance.

Authors:  Stephen D Lawn; Mark P Nicol
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

3.  Multicenter Evaluation of the Xpert Carba-R Assay for Detection and Identification of Carbapenemase Genes in Sputum Specimens.

Authors:  Zhen Cai; Jia Tao; Tianye Jia; Hongyu Fu; Xin Zhang; Mei Zhao; Hong Du; Hua Yu; Bin Shan; Bin Huang; Liang Chen; Yi-Wei Tang; Wei Jia; Fen Qu
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

4.  Rapid Detection of Bacillus anthracis Bloodstream Infections by Use of a Novel Assay in the GeneXpert System.

Authors:  Padmapriya P Banada; Srinidhi Deshpande; Riccardo Russo; Eric Singleton; Darshini Shah; Bhavana Patel; Michele Burday; Ranie Koshy; Qing Wang; Martin Jones; Alexander Gall; Sergey Lokhov; Robert Kwiatkowski; David Persing; Nancy Connell; David Alland
Journal:  J Clin Microbiol       Date:  2017-07-26       Impact factor: 5.948

5.  Mechanical disruption of lysis-resistant bacterial cells by use of a miniature, low-power, disposable device.

Authors:  Peter E Vandeventer; Kris M Weigel; Jose Salazar; Barbara Erwin; Bruce Irvine; Robert Doebler; Ali Nadim; Gerard A Cangelosi; Angelika Niemz
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

Review 6.  Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test.

Authors:  Stephen D Lawn; Peter Mwaba; Matthew Bates; Amy Piatek; Heather Alexander; Ben J Marais; Luis E Cuevas; Timothy D McHugh; Lynn Zijenah; Nathan Kapata; Ibrahim Abubakar; Ruth McNerney; Michael Hoelscher; Ziad A Memish; Giovanni Battista Migliori; Peter Kim; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

7.  Identifying experimental surrogates for Bacillus anthracis spores: a review.

Authors:  David L Greenberg; Joseph D Busch; Paul Keim; David M Wagner
Journal:  Investig Genet       Date:  2010-09-01

8.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

9.  Implications of limits of detection of various methods for Bacillus anthracis in computing risks to human health.

Authors:  Amanda B Herzog; S Devin McLennan; Alok K Pandey; Charles P Gerba; Charles N Haas; Joan B Rose; Syed A Hashsham
Journal:  Appl Environ Microbiol       Date:  2009-07-31       Impact factor: 4.792

Review 10.  Point-of-Care Diagnostics: Recent Developments in a Connected Age.

Authors:  Samiksha Nayak; Nicole R Blumenfeld; Tassaneewan Laksanasopin; Samuel K Sia
Journal:  Anal Chem       Date:  2016-12-13       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.